OR WAIT null SECS
June 20, 2023
The 200,000 square-foot manufacturing plant—coming early next year—is expected to help boost capacity of pharma packaging materials.
June 15, 2023
The series’ marking heads help deliver codes to support both product traceability and anti-counterfeiting efforts.
Expansion expected to create additional production capacity, company says.
June 14, 2023
Changes to 3PL’s facility feature newly-converted controlled room temperature pallets.
June 13, 2023
CDMO’s new facility is expected to be operational by April 2025.
June 12, 2023
The accreditations—granted to the company’s sites in the US, LATAM, and Canada—are given for compliance with specific pharma manufacturer guidelines.
June 05, 2023
Decision is anticipated to boost operational efficiencies for the CDMO.
June 02, 2023
Company is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.
May 30, 2023
Company’s latest report reveals future plans, powered by efforts to divert more of its air shipments to sea.